Abstract
The MEN2A oncogene encodes for a constitutive active member of the RET receptor tyrosine kinase family. Here, we report that MEN2A-RET activates Signal Transducer and Activator of Transcription 3 (STAT3) via two YxxV/Q STAT3 docking sites, Tyr752 and Tyr928. MEN2A-RET induces both Tyr705 and Ser727 phosphorylation of STAT3, and STAT3 serine phosphorylation is required for its maximal transcriptional activity. Stable NIH3T3 cell lines expressing both MEN2A-RET and STAT3α but not STAT3β, are characterized by enhanced proliferation and cyclin-D1 promoter activity, and enhanced growth in soft agar. These data indicate that malignant cell growth induced by MEN2A-RET involves its activation of STAT3.
Similar content being viewed by others
References
Alberti L, Borrello MG, Ghizzoni S, Torriti F, Rizzetti MG, Pierotti MA . 1998 Oncogene 17: 1079–1087
Arighi E, Alberti L, Torriti F, Ghizzoni S, Rizzetti MG, Pelicci G, Pasini B, Bongarzone I, Piutti C, Pierotti MA, Borrello MG . 1997 Oncogene 14: 773–782
Asai N, Iwashita T, Matsuyama M, Takahashi M . 1995 Mol. Cell Biol. 15: 1613–1619
Asai N, Murakami H, Iwashita T, Takahashi M . 1996 J. Biol. Chem. 271: 17644–17649
Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA . 1996 Mol. Cell Biol. 16: 2151–2163
Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L . 1995 Oncogene 11: 2419–2427
Bowman T, Garcia R, Turkson J, Jove R . 2000 Oncogene 19: 2474–2488
Brasier AR, Tate JE, Habener JF . 1989 Biotechniques 7: 1116–1122
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE . 1998 Mol. Cell Biol. 18: 2553–2558
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE . 1999 Cell 98: 295–303
Caldenhoven E, van-Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, De-Groot RP . 1996 J. Biol. Chem. 271: 13221–13227
Cao X, Tay A, Guy GR, Tan YH . 1996 Mol. Cell Biol. 16: 1595–1603
Coffer PJ, Koenderman L, De Groot RP . 2000 Oncogene 19: 2511–2522
Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421
Delegeane AM, Ferland LH, Mellon PL . 1987 Mol. Cell Biol. 7: 3994–4002
DeLellis RA . 1995 Lab. Invest. 72: 494–505
Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA . 1993 Hum. Mol. Genet. 2: 851–856
Durick K, Wu RY, Gill GN, Taylor SS . 1996 J. Biol. Chem. 271: 12691–12694
Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T . 1998 EMBO J. 17: 6670–6677
Goodfellow PJ, Wells Jr SA . 1995 J. Natl. Cancer Inst. 87: 1515–1523
Graham FL, Van der Eb AJ . 1973 Mol. Cell Biol. 2: 607–616
Heim MH, Kerr IM, Stark GR, Darnell Jr JE . 1995 Science 267: 1347–1349
Heinrich PC, Behrmann I, Muller NG, Schaper F, Graeve L . 1998 Biochem. J. 334: 297–314
Herber B, Truss M, Beato M, Muller R . 1994 Oncogene 9: 1295–1304
Ihle JN . 1996 Cell 84: 331–334
Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W . 1998 J. Biol. Chem. 273: 21145–21152
Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M . 2001 Oncogene 20: 1929–1938
Lin TS, Mahajan S, Frank DA . 2000 Oncogene 19: 2496–2504
Liu X, Vega QC, Decker RA, Pandey A, Worby CA, Dixon JE . 1996 J. Biol. Chem. 271: 5309–5312
Lorenzo MJ, Gish GD, Houghton C, Stonehouse TJ, Pawson T, Ponder BA, Smith DP . 1997 Oncogene 14: 763–771
Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L . 1993 Nature 363: 458–460
Pandey A, Liu X, Dixon JE, di Fiore PP, Dixit VM . 1996 J. Biol. Chem. 271: 10607–10610
Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF . 2001 Neuron 29: 171–184
Pasini A, Geneste O, Legrand P, Schlumberger M, Rossel M, Fournier L, Rudkin BB, Schuffenecker I, Lenoir GM, Billaud M . 1997 Oncogene 15: 393–402
Ponder BA . 1999 Cancer Res. 59: 1736s–1741s
Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH . 1995 Science 267: 381–383
Schindler C, Darnell Jr JE . 1995 Annu. Rev. Biochem. 64: 621–651
Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V . 1994 Nature 367: 380–383
Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E, Kruijer W . 2000a Biochem. J. 347: Pt 1 89–96
Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E . 2000b Blood 95: 3765–3770
Segouffin-Cariou C, Billaud M . 2000 J. Biol. Chem. 275: 3568–3576
Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R . 2000 Oncogene 19: 5419–5427
Song JI, Grandis JR . 2000 Oncogene 19: 2489–2495
Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE, Yancopoulos GD . 1995 Science 267: 1349–1353
Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H . 1988 Oncogene 3: 571–578
Takahashi M, Cooper GM . 1987 Mol. Cell Biol. 7: 1378–1385
Taraviras S, Marcos-Gutierrez CV, Durbec P, Jani H, Grigoriou M, Sukumaran M, Wang LC, Hynes M, Raisman G, Pachnis V . 1999 Development 126: 2785–2797
Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R . 1998 Mol. Cell Biol. 18: 2545–2552
Wen Z, Zhong Z, Darnell Jr JE . 1995 Cell 82: 241–250
Zong C, Yan R, August A, Darnell Jr JE, Hanafusa H . 1996 EMBO J. 15: 4515–4525
Zong CS, Zeng L, Jiang Y, Sadowski HB, Wang LH . 1998 J. Biol. Chem. 273: 28065–28072
Acknowledgements
This work was supported by grants from the Dutch Cancer Foundation (RUG 96-1217) and RUG 00-2316).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schuringa, J., Wojtachnio, K., Hagens, W. et al. MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 20, 5350–5358 (2001). https://doi.org/10.1038/sj.onc.1204715
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204715
- Springer Nature Limited
Keywords
This article is cited by
-
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Nature Reviews Clinical Oncology (2018)
-
STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma
Cancer Gene Therapy (2015)
-
Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy
Scientific Reports (2015)
-
KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer
Molecular Cancer (2014)
-
RET revisited: expanding the oncogenic portfolio
Nature Reviews Cancer (2014)